Amlodipine Besylate
Product Images NDC 0615-8429

9 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 0615-8429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine-str-2 (Amlodipine Tabs 8429 8430 8431 1)

Amlodipine-str-2 (Amlodipine Tabs 8429 8430 8431 1)
Chemical structure of the active ingredient Amlodipine Besylate, showing its molecular arrangement including the chlorine-substituted aromatic ring and other functional groups.*
FDA Label Image

Figure 1 (Amlodipine Tabs 8429 8430 8431 2)

Figure 1 (Amlodipine Tabs 8429 8430 8431 2)
A line graph depicting event rates over time (in months) comparing two groups: Amlodipine and Placebo. The y-axis shows event rate from 0.0 to 0.25, and the x-axis represents time up to 24 months. The graph includes a statistical summary with a p-value of 0.003, a hazard ratio of 0.691, and a 95% confidence interval (0.54, 0.88). The number of subjects at risk decreases over time along the x-axis.*
FDA Label Image

Figure 2 (Amlodipine Tabs 8429 8430 8431 3)

Figure 2 (Amlodipine Tabs 8429 8430 8431 3)
A forest plot graph comparing the hazard ratios with 95% confidence intervals for patients treated with Amlodipine versus placebo across various subgroups, including overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease and stenosis, and PCI stent status. The x-axis represents the hazard ratio scale from 0.0 to 2.0.*
FDA Label Image

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 4)

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 4)
This label is for Amlodipine Besylate tablets USP 2.5 mg, supplied in a quantity of 30 tablets. The label features multiple barcodes, lot number 8429-, and mentions packaging by Vanguard Labs in Glasgow, KY. It includes storage instructions at 20°-25°C, and notes the product is for institutional use only. The label also references NCS HealthCare of KY, LLC dba Vanguard Labs as the labeler and Alkem as manufacturer for Ascend.*
FDA Label Image

Amlodipine 2.5mg Tab Unit-dose Label (Amlodipine Tabs 8429 8430 8431 5)

Amlodipine 2.5mg Tab Unit-dose Label (Amlodipine Tabs 8429 8430 8431 5)
Label sheet for Amlodipine Besylate Tablets USP 2.5 mg, repackaged by NCS HealthCare of KY, LLC dba Vangard Labs in Glasgow, KY. The sheet includes multiple identical small labels with drug name, strength, lot number area, expiration date area, and barcode. Below are larger primary labels stating product name, strength, quantity of 30 tablets, storage instructions, manufacturer Alkem for Ascend, and repackaging information with barcodes.*
FDA Label Image

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 6)

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 6)
This image shows a packaging label for Amlodipine Besylate Tablets, USP 5 mg, distributed by NCS HealthCare of KY, LLC dba Vangard Labs. The label includes the proprietary name, strength, lot number, expiration date, and quantity of 30 tablets. It features multiple barcodes and storage instructions, indicating institutional use only. The labeler location is Glasgow, KY.*
FDA Label Image

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 7)

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 7)
Amlodipine Besylate Tablets USP 5 mg tablet labels from NCS HealthCare of KY, LLC dba Vangard Labs. The labels include the drug name, strength, lot number, and barcode. A larger label section at the bottom displays detailed product information including quantity of 30 tablets, storage instructions, NDC number 67877-198-10, manufacturer Alkem for Ascend, and repackaging information by Vangard Labs, Glasgow, KY 42141.*
FDA Label Image

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 8)

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 8)
Amlodipine Besylate tablets USP 10 mg packaging label with barcode and lot information. The label indicates the product is for institutional use only, contains tablets with 10 mg amlodipine besylate equivalent, and is packaged by Vangard Labs, Glasgow, KY. It includes storage instructions and a calendar grid for tracking administration dates.*
FDA Label Image

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 9)

Principal Display Panel (Amlodipine Tabs 8429 8430 8431 9)
Packaging label for Amlodipine Besylate Tablets USP 10 mg, repackaged by Vanguard Labs, Glasgow, KY. The label shows details such as quantity 30 tablets, storage instructions, barcodes, and manufacturing information by Alkem for Ascend. The label includes lot and expiration date fields and indicates the product is Rx only and for institutional use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.